Brief: Vyne Therapeutics Reports Qtrly Loss Per Share 22 Cents

YARROW BIOSCIENCE

17/03/2022 13:33

March 17 (Reuters) - Vyne Therapeutics Inc  VYNE.O :
    * VYNE THERAPEUTICS REPORTS YEAR-END 2021 FINANCIAL RESULTS
AND
PROVIDES CORPORATE UPDATE
    * VYNE THERAPEUTICS - EXPECTS CASH, CASH EQUIVALENTS &
RESTRICTED
CASH AS OF DEC 31, 2021 & PROCEEDS FROM SALE WILL BE SUFFICIENT
TO FUND OPERATIONS THROUGH DEC 31, 2022
    * VYNE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.22
    * VYNE THERAPEUTICS INC - QTRLY ADJUSTED LOSS PER SHARE
$0.20

Source text for Eikon:  ID:nGNX7bpxQJ 
Further company coverage:  VYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))